» Articles » PMID: 24642084

Sucrose Stabilization of Respiratory Syncytial Virus (RSV) During Nebulization and Experimental Infection

Overview
Journal BMC Res Notes
Publisher Biomed Central
Date 2014 Mar 20
PMID 24642084
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Respiratory syncytial virus (RSV) is a common respiratory pathogen that can cause severe pneumonia. In vivo studies of RSV can be difficult due to variation in viral infection and disease severity in some animal models. Factors that may contribute to the variation are decreases in viral titer due to preparation and storage and method of virus administration. Nebulization is one method of RSV administration that provides even distribution of virus to all lung lobes; however, the exact quantity of the virus killed by nebulization is not defined. To test the hypothesis that sucrose enhances RSV stability and infectivity, a series of in vitro experiments were conducted with RSV strain Memphis 37 stored at varying concentrations (0%, 3%, 5%, 8%, 10%, 15%, and 20%) of sucrose as a possible cryo- and nebulization protectant. The optimal in vitro concentration was then assessed in vivo in a lamb model.

Methods: Prior to titering the virus on HEp-2 cells, the various virus solutions were subjected to one freeze-thaw cycle and one nebulization cycle. Forty-eight hours after viral plating, infectious foci were detected and counted using immunofluorescent imaging. Titers were determined after freeze-thaw and after freeze-thaw followed by nebulization, then compared to the stock titers (before freezing) as well as to one another to determine the loss of infectivity. To further test this in vivo, lambs 2 to 3-days-old were infected via nebulization with RSV using inoculate containing either 20% sucrose or no sucrose followed by assessments of infection severity.

Results: Nebulization of virus in 0% sucrose resulted in a 0.580 log reduction in infectivity while virus in 20% sucrose exhibited a 0.297 log reduction. In vivo studies demonstrated that 20% sucrose enhanced RSV lesions and antigen distribution.

Conclusions: The data suggests that both nebulization and freeze-thawing of RSV in the absence of sucrose cause unacceptable losses in viral infectivity and that sucrose acts as a RSV protectant in both regards.

Citing Articles

Therapeutic efficacy of JNJ-49214698, an RSV fusion inhibitor, in RSV-infected neonatal lambs.

Alnajjar S, Larios-Mora A, Van-Geelen A, Gallup J, Koul A, Rigaux P J Gen Virol. 2024; 105(12).

PMID: 39661432 PMC: 11634040. DOI: 10.1099/jgv.0.002056.


Aerosolized delivery of ESKAPE pathogens for murine pneumonia models.

Rox K, Medina E Sci Rep. 2024; 14(1):2558.

PMID: 38297183 PMC: 10830452. DOI: 10.1038/s41598-024-52958-9.


Ozone inactivation of airborne influenza and lack of resistance of respiratory syncytial virus to aerosolization and sampling processes.

Dubuis M, Racine E, Vyskocil J, Turgeon N, Tremblay C, Mukawera E PLoS One. 2021; 16(7):e0253022.

PMID: 34252093 PMC: 8274922. DOI: 10.1371/journal.pone.0253022.


Characterizing and Quantifying Arbovirus Transmission by Using Forced Salivation and Analysis of Bloodmeals.

Miller M, Sorensen M, Markle E, Clarkson T, Knight A, Savran M Insects. 2021; 12(4).

PMID: 33808172 PMC: 8065531. DOI: 10.3390/insects12040304.


Streptococcus pneumoniae serotype 22F infection in respiratory syncytial virus infected neonatal lambs enhances morbidity.

Alnajjar S, Sitthicharoenchai P, Gallup J, Ackermann M, Verhoeven D PLoS One. 2021; 16(3):e0235026.

PMID: 33705390 PMC: 7951856. DOI: 10.1371/journal.pone.0235026.


References
1.
Collins P, Melero J . Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. Virus Res. 2011; 162(1-2):80-99. PMC: 3221877. DOI: 10.1016/j.virusres.2011.09.020. View

2.
Law T, HULL R . The stabilizing effect of sucrose upon respiratory syncytial virus infectivity. Proc Soc Exp Biol Med. 1968; 128(2):515-8. DOI: 10.3181/00379727-128-33054. View

3.
Abed Y, Boivin G . Treatment of respiratory virus infections. Antiviral Res. 2006; 70(2):1-16. PMC: 7114251. DOI: 10.1016/j.antiviral.2006.01.006. View

4.
Sow F, Gallup J, Krishnan S, Patera A, Suzich J, Ackermann M . Respiratory syncytial virus infection is associated with an altered innate immunity and a heightened pro-inflammatory response in the lungs of preterm lambs. Respir Res. 2011; 12:106. PMC: 3170232. DOI: 10.1186/1465-9921-12-106. View

5.
Hon K, Leung T, Cheng W, Ko N, Tang W, Wong W . Respiratory syncytial virus morbidity, premorbid factors, seasonality, and implications for prophylaxis. J Crit Care. 2012; 27(5):464-8. DOI: 10.1016/j.jcrc.2011.12.001. View